Early first-check signaling backer oriented toward alternative-protein infrastructure (ingredients, fermentation), founded by animal advocates, optimizing targeting animal-impact alongside providing CPG operational expertise via CEO Lisa Feria.
Ranked by shared stages, industries, geography, cheque size and investor type. 400 related investors in the directory.
Women-led VC systematically backs clinically rigorous, behaviorally grounded wellbeing nascent-stage companies tackling stigmatized areas—alcohol use disorder, menopause, mental health—using stigma as an investing edge and insisting on consumer-grade UX. With a disciplined investment approach, the team drives value for both founders and investors.
Nascent-stage investor spanning service-heavy care delivery and deep neuro/bio/AR frontier tech, delivering specialized neuro+AI+delivery expertise that bridges physical clinics and cutting-edge technologies. With a disciplined investment approach, the team drives value for both founders and investors.
Spearheaded by a former Google X founder, the firm brings a moonshot lab prototyping philosophy anchored in a structured Triad investment thesis encompassing deep technology, reimagined unit economics, and climate-positive outcomes. It stands out by offering hands-on prototyping assistance and reverse-engineering of unit-economics models for its portfolio.
Seed and early-phase investor that creates and funds biotech young companies, emphasizing company creation. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Is dedicated to impactful businesses aiming to positively transform the world's food system.
Seed-stage investor in dual-use deep tech (six verticals) with an invite-only U.S. Service Academy alumni syndicate that co-invests, sources, vets deals, presents post-investment support, and runs a veteran-led track. The firm continues to build its presence across the venture capital landscape.
